Emerging strategies in stimuli-responsive prodrug nanosystems for cancer therapy
Prodrugs are chemically modified drug molecules that are inactive before administration. After administration, they are converted in situ to parent drugs and induce the mechanism of action. The development of prodrugs has upgraded conventional drug treatments in terms of bioavailability, targeting,...
Main Authors: | Ding, Chendi, Chen, Chunbo, Zeng, Xiaowei, Chen, Hongzhong, Zhao, Yanli |
---|---|
Other Authors: | School of Chemistry, Chemical Engineering and Biotechnology |
Format: | Journal Article |
Language: | English |
Published: |
2023
|
Subjects: | |
Online Access: | https://hdl.handle.net/10356/165552 |
Similar Items
-
Nanomaterials and Nanosystems for Biomedical Applications [electronic resource]: /
by: Mozafari, M.Reza, et al.
Published: (2007) -
Nanosystem characterization tools in the life sciences /
by: Kumar, C. S. S. R. (Challa S. S. R.)
Published: (2006) -
Light-responsive prodrug-based supramolecular nanosystems for site-specific combination therapy of cancer
by: Phua, Fiona Soo Zeng, et al.
Published: (2020) -
NIR-light-activated combination therapy with a precise ratio of photosensitizer and prodrug using a host-guest strategy
by: Chen, Hongzhong, et al.
Published: (2020) -
Self-assembled oxaliplatin(IV) prodrug-porphyrin conjugate for combinational photodynamic therapy and chemotherapy
by: Lim, Wei Qi, et al.
Published: (2021)